Aclidiniumbromid forbedrer lungefunktion og reducerer åndenød hos patienter med KOL

Charlotte Suppli Ulrik

Aclidiniumbromid forbedrer lungefunktion og reducerer åndenød hos patienter med KOL

Translated title of the contribution: Aclidinium bromide improves the lung function and reduces dyspnoea in patients with COPD.

Charlotte Suppli Ulrik

Department of Clinical Medicine

Research output: Contribution to journal › Journal article › Research › peer-review

Abstract

Long-acting bronchodilators are central for treatment of COPD. This short review provides an overview of studies evaluating the efficacy of aclidinium bromide, a long-acting anticholinergic bronchodilator, for the treatment of COPD. Twice-daily dosing of aclidinium leads to clinically important improvements in forced expiratory volume in 1 second, health status, use of rescue medication, day-time dyspnoea and exercise tolerance. The available studies also suggest an effect on night-time dyspnoea and exacerbation rate in patients with COPD. Aclidinium seems to have potential for a significant role in the future management of COPD.

Translated title of the contribution	Aclidinium bromide improves the lung function and reduces dyspnoea in patients with COPD.
Original language	Danish
Journal	Ugeskrift for Laeger
Volume	176
Issue number	28
Pages (from-to)	1296-1299
Number of pages	4
ISSN	0041-5782
Publication status	Published - 31 Mar 2014

Library access?

Check availability at the Royal Danish Library

Cite this

@article{358e314c538a4743b4fc2c48672a1a22,

title = "Aclidiniumbromid forbedrer lungefunktion og reducerer {\aa}nden{\o}d hos patienter med KOL",

abstract = "Long-acting bronchodilators are central for treatment of COPD. This short review provides an overview of studies evaluating the efficacy of aclidinium bromide, a long-acting anticholinergic bronchodilator, for the treatment of COPD. Twice-daily dosing of aclidinium leads to clinically important improvements in forced expiratory volume in 1 second, health status, use of rescue medication, day-time dyspnoea and exercise tolerance. The available studies also suggest an effect on night-time dyspnoea and exacerbation rate in patients with COPD. Aclidinium seems to have potential for a significant role in the future management of COPD.",

author = "Ulrik, {Charlotte Suppli}",

year = "2014",

month = mar,

day = "31",

language = "Dansk",

volume = "176",

pages = "1296--1299",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "28",

}

TY - JOUR

T1 - Aclidiniumbromid forbedrer lungefunktion og reducerer åndenød hos patienter med KOL

AU - Ulrik, Charlotte Suppli

PY - 2014/3/31

Y1 - 2014/3/31

N2 - Long-acting bronchodilators are central for treatment of COPD. This short review provides an overview of studies evaluating the efficacy of aclidinium bromide, a long-acting anticholinergic bronchodilator, for the treatment of COPD. Twice-daily dosing of aclidinium leads to clinically important improvements in forced expiratory volume in 1 second, health status, use of rescue medication, day-time dyspnoea and exercise tolerance. The available studies also suggest an effect on night-time dyspnoea and exacerbation rate in patients with COPD. Aclidinium seems to have potential for a significant role in the future management of COPD.

AB - Long-acting bronchodilators are central for treatment of COPD. This short review provides an overview of studies evaluating the efficacy of aclidinium bromide, a long-acting anticholinergic bronchodilator, for the treatment of COPD. Twice-daily dosing of aclidinium leads to clinically important improvements in forced expiratory volume in 1 second, health status, use of rescue medication, day-time dyspnoea and exercise tolerance. The available studies also suggest an effect on night-time dyspnoea and exacerbation rate in patients with COPD. Aclidinium seems to have potential for a significant role in the future management of COPD.

M3 - Tidsskriftartikel

C2 - 25291997

SN - 0041-5782

VL - 176

SP - 1296

EP - 1299

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 28

ER -